Cocrystal Pharma, Inc.
COCPBiotechnology
$0.98−1.01%As of Oct 29vs prior close
- Market cap
- $18.9M
- P/E (TTM)
- –
- From 52W high
- −37.58%
- EPS (LTM)
- -$0.75
- Revenue (YE20)
- $2M
- Dividend yield
- 0.00%
Nomior Score
35
Steady ProfileSpeculativeBottom 21% of the scored universe
Growth—
Quality28
Value—
Momentum48
Resilience33
Growth
−69.32%revenue a year over 1 fiscal year
YE19 $6.6MYE20 $2M
Connections
Revenue to profitQ2 YE26
The operating loss was 3032% of revenue.
Who owns it
1fund